Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy

Lonzetta Neal, Nicole P. Sandhu, Tina J Hieken, Katrina Nesta Glazebrook, Maire Brid Mac Bride, Christina A. Dilaveri, Dietlind L. Wahner-Roedler, Karthik Ghosh, Daniel W Visscher

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Imaging abnormalities detected by mammographic screening often lead to diagnostic evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy (CNB) to exclude malignancy. Most CNBs reveal benign pathological alterations, termed benign breast disease (BBD). Adoption of CNB presents challenges with pathologic classification of breast abnormalities and management of patients with benign or atypical histological findings. Patient management and counseling after CNB diagnosis of BBD depends on postbiopsy determination of radiologic-pathologic concordancy. Communication between radiologists and pathologists is crucial in patient management. Management is dependent on the histological type of BBD. Patients with concordant pathologic imaging results can be reassured of benign biopsy findings and advised about the future risk of developing breast cancer. Surgical consultation is advised for patients with discordant findings, symptomatic patients, and high-risk lesions. This review highlights benign breast lesions that are encountered on CNB and summarizes management strategies. For this review, we conducted a search of PubMed, with no date limitations, and used the following search terms (or a combination of terms): atypical ductal hyperplasia, atypical hyperplasia, atypical lobular hyperplasia, benign breast disease, cellular fibroepithelial lesions, columnar cell lesions, complex sclerosing lesion, core needle biopsy, fibroadenomas, flat epithelial atypia, lobular carcinoma in situ, lobular neoplasia, mucocele-like lesions, phyllodes tumor, pseudoangiomatous stromal hyperplasia, radial scar, and vascular lesions. The selection of references included in this review was based on study relevance and quality. We used additional articles culled from the bibliographies of retrieved articles to examine the published evidence for risk factors of BBD.

Original languageEnglish (US)
Pages (from-to)536-547
Number of pages12
JournalMayo Clinic Proceedings
Volume89
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Large-Core Needle Biopsy
Breast Diseases
Breast
Hyperplasia
Phyllodes Tumor
Mucocele
Fibroadenoma
Carcinoma, Intraductal, Noninfiltrating
Bibliography
PubMed
Cicatrix
Blood Vessels
Counseling
Neoplasms
Referral and Consultation
Communication
Breast Neoplasms
Biopsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. / Neal, Lonzetta; Sandhu, Nicole P.; Hieken, Tina J; Glazebrook, Katrina Nesta; Bride, Maire Brid Mac; Dilaveri, Christina A.; Wahner-Roedler, Dietlind L.; Ghosh, Karthik; Visscher, Daniel W.

In: Mayo Clinic Proceedings, Vol. 89, No. 4, 2014, p. 536-547.

Research output: Contribution to journalArticle

Neal, Lonzetta ; Sandhu, Nicole P. ; Hieken, Tina J ; Glazebrook, Katrina Nesta ; Bride, Maire Brid Mac ; Dilaveri, Christina A. ; Wahner-Roedler, Dietlind L. ; Ghosh, Karthik ; Visscher, Daniel W. / Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. In: Mayo Clinic Proceedings. 2014 ; Vol. 89, No. 4. pp. 536-547.
@article{56b1c14a9f1048419e994271f5283df2,
title = "Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy",
abstract = "Imaging abnormalities detected by mammographic screening often lead to diagnostic evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy (CNB) to exclude malignancy. Most CNBs reveal benign pathological alterations, termed benign breast disease (BBD). Adoption of CNB presents challenges with pathologic classification of breast abnormalities and management of patients with benign or atypical histological findings. Patient management and counseling after CNB diagnosis of BBD depends on postbiopsy determination of radiologic-pathologic concordancy. Communication between radiologists and pathologists is crucial in patient management. Management is dependent on the histological type of BBD. Patients with concordant pathologic imaging results can be reassured of benign biopsy findings and advised about the future risk of developing breast cancer. Surgical consultation is advised for patients with discordant findings, symptomatic patients, and high-risk lesions. This review highlights benign breast lesions that are encountered on CNB and summarizes management strategies. For this review, we conducted a search of PubMed, with no date limitations, and used the following search terms (or a combination of terms): atypical ductal hyperplasia, atypical hyperplasia, atypical lobular hyperplasia, benign breast disease, cellular fibroepithelial lesions, columnar cell lesions, complex sclerosing lesion, core needle biopsy, fibroadenomas, flat epithelial atypia, lobular carcinoma in situ, lobular neoplasia, mucocele-like lesions, phyllodes tumor, pseudoangiomatous stromal hyperplasia, radial scar, and vascular lesions. The selection of references included in this review was based on study relevance and quality. We used additional articles culled from the bibliographies of retrieved articles to examine the published evidence for risk factors of BBD.",
author = "Lonzetta Neal and Sandhu, {Nicole P.} and Hieken, {Tina J} and Glazebrook, {Katrina Nesta} and Bride, {Maire Brid Mac} and Dilaveri, {Christina A.} and Wahner-Roedler, {Dietlind L.} and Karthik Ghosh and Visscher, {Daniel W}",
year = "2014",
doi = "10.1016/j.mayocp.2014.02.004",
language = "English (US)",
volume = "89",
pages = "536--547",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy

AU - Neal, Lonzetta

AU - Sandhu, Nicole P.

AU - Hieken, Tina J

AU - Glazebrook, Katrina Nesta

AU - Bride, Maire Brid Mac

AU - Dilaveri, Christina A.

AU - Wahner-Roedler, Dietlind L.

AU - Ghosh, Karthik

AU - Visscher, Daniel W

PY - 2014

Y1 - 2014

N2 - Imaging abnormalities detected by mammographic screening often lead to diagnostic evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy (CNB) to exclude malignancy. Most CNBs reveal benign pathological alterations, termed benign breast disease (BBD). Adoption of CNB presents challenges with pathologic classification of breast abnormalities and management of patients with benign or atypical histological findings. Patient management and counseling after CNB diagnosis of BBD depends on postbiopsy determination of radiologic-pathologic concordancy. Communication between radiologists and pathologists is crucial in patient management. Management is dependent on the histological type of BBD. Patients with concordant pathologic imaging results can be reassured of benign biopsy findings and advised about the future risk of developing breast cancer. Surgical consultation is advised for patients with discordant findings, symptomatic patients, and high-risk lesions. This review highlights benign breast lesions that are encountered on CNB and summarizes management strategies. For this review, we conducted a search of PubMed, with no date limitations, and used the following search terms (or a combination of terms): atypical ductal hyperplasia, atypical hyperplasia, atypical lobular hyperplasia, benign breast disease, cellular fibroepithelial lesions, columnar cell lesions, complex sclerosing lesion, core needle biopsy, fibroadenomas, flat epithelial atypia, lobular carcinoma in situ, lobular neoplasia, mucocele-like lesions, phyllodes tumor, pseudoangiomatous stromal hyperplasia, radial scar, and vascular lesions. The selection of references included in this review was based on study relevance and quality. We used additional articles culled from the bibliographies of retrieved articles to examine the published evidence for risk factors of BBD.

AB - Imaging abnormalities detected by mammographic screening often lead to diagnostic evaluations, with suspicious abnormalities subjected to image-guided core needle biopsy (CNB) to exclude malignancy. Most CNBs reveal benign pathological alterations, termed benign breast disease (BBD). Adoption of CNB presents challenges with pathologic classification of breast abnormalities and management of patients with benign or atypical histological findings. Patient management and counseling after CNB diagnosis of BBD depends on postbiopsy determination of radiologic-pathologic concordancy. Communication between radiologists and pathologists is crucial in patient management. Management is dependent on the histological type of BBD. Patients with concordant pathologic imaging results can be reassured of benign biopsy findings and advised about the future risk of developing breast cancer. Surgical consultation is advised for patients with discordant findings, symptomatic patients, and high-risk lesions. This review highlights benign breast lesions that are encountered on CNB and summarizes management strategies. For this review, we conducted a search of PubMed, with no date limitations, and used the following search terms (or a combination of terms): atypical ductal hyperplasia, atypical hyperplasia, atypical lobular hyperplasia, benign breast disease, cellular fibroepithelial lesions, columnar cell lesions, complex sclerosing lesion, core needle biopsy, fibroadenomas, flat epithelial atypia, lobular carcinoma in situ, lobular neoplasia, mucocele-like lesions, phyllodes tumor, pseudoangiomatous stromal hyperplasia, radial scar, and vascular lesions. The selection of references included in this review was based on study relevance and quality. We used additional articles culled from the bibliographies of retrieved articles to examine the published evidence for risk factors of BBD.

UR - http://www.scopus.com/inward/record.url?scp=84898665976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898665976&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2014.02.004

DO - 10.1016/j.mayocp.2014.02.004

M3 - Article

C2 - 24684875

AN - SCOPUS:84898665976

VL - 89

SP - 536

EP - 547

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -